Skip to main content
ENTX
NASDAQ Life Sciences

Entera Bio Projects Funding Sufficiency Through Q1 2027, Addressing Going Concern

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1.3
Mkt Cap
$60.609M
52W Low
$0.91
52W High
$3.22
52W Position info
43% above low
Off High info
60% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

ENTX sits 43% above its 52-week low of $0.91.

Summary

Entera Bio announced it sees its funding as sufficient to support operations through the first quarter of 2027. This is a highly material positive development for the company, especially in light of its last 10-K filing (2026-03-27) which included a going concern warning and indicated a very short cash runway. The projection of nearly a year of funding runway significantly de-risks the company's financial position and provides a clearer path for advancing its clinical programs. This news directly addresses a critical financial concern and is likely to be viewed favorably by investors, potentially impacting the stock price.

At the time of this announcement, ENTX was trading at $1.30 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $60.6M. The 52-week trading range was $0.91 to $3.22. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

ENTX - Latest Insights

ENTX
Oct 14, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $2.52
Real-time Price: $3.05 info
Change: +$0.530 (+21%) info
Market Cap: $530.463M info
ENTX
Oct 13, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.60
Real-time Price: $3.05 info
Change: +$0.450 (+17%) info
Market Cap: $530.463M info
ENTX
Sep 23, 2026, 4:05 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $2.81
Real-time Price: $3.05 info
Change: +$0.240 (+9%) info
Market Cap: $530.463M info
ENTX
Aug 28, 2026, 4:13 PM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $3.03
Real-time Price: $3.05 info
Change: +$0.020 (+0.66%) info
Market Cap: $530.463M info
ENTX
Aug 07, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.85
Real-time Price: $3.05 info
Change: +$0.200 (+7%) info
Market Cap: $530.463M info